← Back
Data updated: Jun 12, 2026
SANTARUS INC
Pharma Pharmaceuticals
SANTARUS INC is a pharmaceutical company with 3 FDA-approved products.
2004
Since
3
Drugs
-
Trials
0
New Drugs (2yr)
SANTARUS INC's Key Drugs
SANTARUS INC's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
No active drugs
SANTARUS INC's Recent FDA Approvals
New NDA/BLA approvals for SANTARUS INC over the last two years — novel drugs only, excluding generics and label supplements.
No recent approvals
SANTARUS INC's Therapeutic Areas
Disease areas where SANTARUS INC has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.
No indication data
SANTARUS INC Pipeline Snapshot
Active clinical trials for SANTARUS INC across all therapeutic areas, from ClinicalTrials.gov.
No active pipeline data available
Pro Expected Approvals & Milestones
Loading detailed analysis...
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Active trial monitoring
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Unlock Full Intelligence
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 2004-12-21
- Latest
- 2018-11-07
- Applications
- 4
FDA Sponsor Names
SANTARUS INCSANTARUS